Professor, Pathology, UCSD School of Medicine
Pathology
Dr. Scott R. Vandenberg, MD
|
|
Give Review
Dr. Scott R. Vandenberg works in the field of Pathology. He went to Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine Scott Vandenberg is also published. He has 41 publications published. The lastest publication: "A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.'
Publications
- A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.
- Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria).
- Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.
- 78 year old male with dysphagia and dysarthria.
- Ultrashort Echo Time (UTE) Magnetic Resonance Imaging of the Short T2 Components in White Matter of the Brain Using a Clinical 3T Scanner.
- Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.
- PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes.
- Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors.
- A Kinome-Wide RNAi Screen in Drosophila Glia Reveals That the RIO Kinases Mediate Cell Proliferation and Survival through TORC2-Akt Signaling in Glioblastoma.
- Expression of miR-124 inhibits growth of medulloblastoma cells.
- Recurrent pediatric central nervous system low-grade gliomas: the role of surveillance neuroimaging in asymptomatic children.
- EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway.
- Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.
- Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
- MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas.
- DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.
- Non-stem cell origin for oligodendroglioma.
- Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.
- Pleiotropic role for MYCN in medulloblastoma.
- A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.
- Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.
- Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival.
- Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging.
- Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors.
- Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.
- Post-radiation reactive changes in a single vertebral body mimicking metastatic pineoblastoma.
- Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.
- Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
- p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts.
- Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective.
- In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas.
- Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas.
- Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased pr...
- Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas.
- Indicators of hippocampal neurogenesis are altered by 56Fe-particle irradiation in a dose-dependent manner.
- Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice.
- Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis.
- Immunophenotype of pleomorphic xanthoastrocytoma.
- Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation.
- Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM.
Schools
Stanford University
Doctors Specialties
- Neuropathology
- Pathology
Accepted Insurances
Education
-
University of Virginia -
Stanford University -
University of Colorado -
Stanford University School of Medicine
Hospital
-
UC San Diego Health -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Jack D. Bui, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mariah R. Baughn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Saskia Boisot, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kurt Benirschke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly J. Bethel, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kurt R. Mathews, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward H. Koo, MD |
|
|
Dr. Howard S. Robin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie B. Steele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Subhojit Roy, MD
This Doctor is OpenDoctor Recommended.
|